H.R.1734

TRANQ Research Act

Date of Vote: May 11, 2023

Chamber of Origin: HouseCongress: 118th

Roll Call Number: 212 | Session Number: 1

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other emerging substances of concern.1

Turning Point Action’s Position

Turning Point Action Supports

Voted YEA

355
51.27% REPUBLICANS48.73% DEMOCRATS0% INDEPENDENTS

VOTED NAY

0
0% REPUBLICANS0% DEMOCRATS0% INDEPENDENTS
Search by Party

Voted yea

Aaron BeanUS CongressFlorida
Session Score:93.33
Adam SmithUS CongressWashington
Session Score:6.67
Adrian SmithUS CongressNebraska
Session Score:93.33
Adriano EspaillatUS CongressNew York
Session Score:6.67
Al GreenUS CongressTexas
Session Score:10.00
Alexandria Ocasio-CortezUS CongressNew York
Session Score:6.67

Voted nay

No legislators have been found in this category

Not voting

Daniel MeuserUS CongressPennsylvania
Session Score:93.33
Debbie DingellUS CongressMichigan
Session Score:10.00
Diana DeGetteUS CongressColorado
Session Score:6.67
Henry C. "Hank" Jr. JohnsonUS CongressGeorgia
Session Score:10.00
Jared MoskowitzUS CongressFlorida
Session Score:40.00
Mike QuigleyUS CongressIllinois
Session Score:23.33

Present

No legislators have been found in this category

Abstaining

No legislators have been found in this category
Donate

DONATE

Our mission is unachievable without your help. We accept a wide range of donation options to ensure the preservation of this great country!

Donate NowDonate Now

Turning Point Action (TPAction) is a 501(c)(4) organization. We exist to equip and empower all generations to engage in grassroots activism and emerge as leaders in their communities.

Subscribe for TPACTION News, Updates, and Events

© Copyright 2025 | Turning Point Action (TPAction) is a 501(c)(4) organization